2024 approvals: Summary of 12 new 💊indications in heme malignancies by FDA:

1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib

#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm